4D Molecular Therapeutics (FDMT) Financial Statements
Price: $3.06
Market Cap: $141.69M
Avg Volume: 828.21K
Market Cap: $141.69M
Avg Volume: 828.21K
Country: US
Industry: Biotechnology
Sector: Healthcare
Industry: Biotechnology
Sector: Healthcare
Overview of Financial Statements
Financial statements are records that provide an overview of a company's financial performance and position. There are three main types of financial statements:
- Income Statement: Shows the company's revenue, expenses, and profit over a specific period.
- Balance Sheet: Provides a snapshot of the company's assets, liabilities, and equity at a specific point in time.
- Cash Flow Statement: Details the cash inflows and outflows from operating, investing, and financing activities over a period.
This page presents both annual and quarterly data for these financial statements. The charts below provide a visual representation of the key metrics from each statement, helping you to quickly understand the financial health of 4D Molecular Therapeutics.
Income Statement
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 | December 31, 2018 | December 31, 2017 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $37.00K | $20.72M | $3.13M | $18.04M | $13.61M | $6.99M | $14.13M | $5.79M |
| Cost of Revenue | $- | $97.10M | $3.88M | $3.02M | $53.04M | $38.72M | $18.36M | $13.57M |
| Gross Profit | $37.00K | $-76.37M | $-751.00K | $15.02M | $-39.43M | $-31.73M | $-4.23M | $-7.78M |
| Gross Profit Ratio | 100.00% | -368.54% | -24.00% | 83.26% | -289.64% | -454.22% | -29.95% | -134.42% |
| Research and Development Expenses | $141.30M | $97.10M | $80.25M | $61.36M | $53.04M | $38.72M | $18.36M | $13.57M |
| General and Administrative Expenses | $46.58M | $36.49M | $32.91M | $28.01M | $17.24M | $13.89M | $6.17M | $3.49M |
| Selling and Marketing Expenses | $- | $- | $- | $- | $- | $- | $- | $- |
| Selling General and Administrative Expenses | $46.58M | $36.49M | $32.91M | $28.01M | $17.24M | $13.89M | $6.17M | $3.49M |
| Other Expenses | $- | $- | $2.54M | $16.00K | $-181.00K | $-46.00K | $-2.00K | $-40.00K |
| Operating Expenses | $187.88M | $133.59M | $113.16M | $89.37M | $70.28M | $52.61M | $24.53M | $17.06M |
| Cost and Expenses | $187.88M | $133.59M | $113.16M | $89.37M | $70.28M | $52.61M | $24.53M | $17.06M |
| Interest Income | $27.05M | $12.21M | $2.57M | $137.00K | $152.00K | $1.50M | $850.00K | $89.00K |
| Interest Expense | $- | $- | $- | $- | $- | $- | $- | $- |
| Depreciation and Amortization | $- | $5.75M | $3.88M | $3.02M | $1.44M | $1.00M | $697.00K | $626.00K |
| EBITDA | $-187.84M | $-107.12M | $-106.15M | $-68.31M | $-55.22M | $-44.62M | $-9.70M | $-10.65M |
| EBITDA Ratio | -507678.38% | -516.90% | -3392.52% | -378.72% | -405.68% | -638.75% | -68.66% | -183.87% |
| Operating Income | $-187.84M | $-112.87M | $-110.03M | $-71.33M | $-56.66M | $-50.76M | $-10.40M | $-11.27M |
| Operating Income Ratio | -507678.38% | -544.65% | -3516.52% | -395.46% | -416.28% | -726.65% | -73.60% | -194.68% |
| Total Other Income Expenses Net | $26.97M | $12.03M | $2.54M | $16.00K | $-29.00K | $1.46M | $848.00K | $49.00K |
| Income Before Tax | $-160.87M | $-100.84M | $-107.49M | $-71.32M | $-56.69M | $-49.31M | $-9.55M | $-11.22M |
| Income Before Tax Ratio | -434778.38% | -486.59% | -3435.41% | -395.37% | -416.49% | -705.78% | -67.59% | -193.83% |
| Income Tax Expense | $- | $- | $-6.42M | $-3.02M | $-152.00K | $3.63M | $848.00K | $-89.00K |
| Net Income | $-160.87M | $-100.84M | $-101.08M | $-68.30M | $-56.54M | $-52.94M | $-9.55M | $-11.22M |
| Net Income Ratio | -434778.38% | -486.59% | -3230.30% | -378.63% | -415.38% | -757.79% | -67.59% | -193.83% |
| EPS | $-2.98 | $-2.58 | $-3.12 | $-2.46 | $-2.12 | $-2.00 | $-0.76 | $-0.76 |
| EPS Diluted | $-2.98 | $-2.58 | $-3.12 | $-2.46 | $-2.12 | $-2.00 | $-0.76 | $-0.76 |
| Weighted Average Shares Outstanding | 53.94M | 39.13M | 32.35M | 27.73M | 26.68M | 26.49M | 12.52M | 14.84M |
| Weighted Average Shares Outstanding Diluted | 53.94M | 39.13M | 32.35M | 27.73M | 26.68M | 26.49M | 12.52M | 14.84M |
| SEC Filing | Source | Source | Source | Source | Source | Source | Source | Source |
Balance Sheet
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 | December 31, 2018 | December 31, 2017 |
|---|---|---|---|---|---|---|---|---|
| Cash and Cash Equivalents | $149.34M | $249.11M | $218.64M | $315.43M | $276.73M | $49.65M | $91.76M | $23.85M |
| Short Term Investments | $275.54M | $39.12M | $161.20M | $94.78M | $- | $- | $- | $- |
| Cash and Short Term Investments | $424.88M | $288.23M | $218.64M | $315.43M | $276.73M | $49.65M | $91.76M | $23.85M |
| Net Receivables | $- | $- | $- | $47.00K | $1.49M | $978.00K | $1.12M | $321.00K |
| Inventory | $- | $- | $-5.79M | $-8.50M | $- | $- | $- | $1 |
| Other Current Assets | $10.05M | $8.36M | $6.96M | $8.46M | $8.89M | $1.88M | $783.00K | $328.00K |
| Total Current Assets | $434.93M | $296.59M | $220.51M | $315.43M | $282.66M | $52.51M | $94.07M | $24.50M |
| Property Plant Equipment Net | $40.61M | $31.66M | $35.35M | $28.95M | $5.07M | $5.05M | $2.47M | $2.72M |
| Goodwill | $- | $- | $- | $- | $- | $- | $- | $- |
| Intangible Assets | $- | $- | $- | $- | $- | $- | $- | $- |
| Goodwill and Intangible Assets | $- | $- | $- | $- | $- | $- | $- | $- |
| Long Term Investments | $- | $10.95M | $4.91M | $67.65M | $- | $- | $- | $- |
| Tax Assets | $- | $- | $- | $- | $- | $- | $- | $- |
| Other Non-Current Assets | $84.84M | $684.00K | $1.08M | $-58.55M | $602.00K | $677.00K | $429.00K | $105.00K |
| Total Non-Current Assets | $125.45M | $43.30M | $41.34M | $38.06M | $5.67M | $5.73M | $2.90M | $2.82M |
| Other Assets | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Assets | $560.38M | $339.89M | $261.85M | $353.49M | $288.33M | $58.23M | $96.97M | $27.32M |
| Account Payables | $4.39M | $3.52M | $3.32M | $4.76M | $1.79M | $1.74M | $954.00K | $460.00K |
| Short Term Debt | $5.64M | $3.15M | $5.31M | $2.46M | $- | $- | $- | $- |
| Tax Payables | $- | $- | $- | $- | $- | $- | $93.00K | $51.00K |
| Deferred Revenue | $257.00K | $273.00K | $884.00K | $2.60M | $6.59M | $5.86M | $4.91M | $4.38M |
| Other Current Liabilities | $18.87M | $12.01M | $6.74M | $9.03M | $8.37M | $5.35M | $2.10M | $1.01M |
| Total Current Liabilities | $29.15M | $18.95M | $15.73M | $16.34M | $16.74M | $12.96M | $8.05M | $5.91M |
| Long Term Debt | $18.97M | $11.52M | $13.47M | $15.22M | $- | $- | $- | $- |
| Deferred Revenue Non-Current | $- | $972.00K | $1.08M | $2.49M | $13.23M | $13.60M | $13.08M | $22.19M |
| Deferred Tax Liabilities Non-Current | $- | $- | $- | $- | $- | $- | $- | $- |
| Other Non-Current Liabilities | $1.66M | $617.00K | $233.00K | $334.00K | $1.97M | $104.65M | $103.43M | $18.81M |
| Total Non-Current Liabilities | $20.63M | $13.11M | $14.78M | $18.04M | $15.20M | $118.25M | $116.50M | $41.00M |
| Other Liabilities | $- | $- | $- | $526.10M | $- | $- | $- | $- |
| Total Liabilities | $49.78M | $32.06M | $30.51M | $560.48M | $31.94M | $131.20M | $124.56M | $46.91M |
| Preferred Stock | $- | $- | $- | $- | $288.33M | $102.98M | $102.98M | $18.51M |
| Common Stock | $5.00K | $4.00K | $3.00K | $3.00K | $3.00K | $1.00K | $1.00K | $1.00K |
| Retained Earnings | $-576.20M | $-415.33M | $-314.49M | $-207.00M | $-135.68M | $-79.03M | $-30.03M | $-20.48M |
| Accumulated Other Comprehensive Income Loss | $- | $16.00K | $-1.20M | $-423.00K | $-288.33M | $-102.98M | $-102.98M | $-18.51M |
| Other Total Stockholders Equity | $1.09B | $723.14M | $547.02M | $526.52M | $103.73M | $6.05M | $2.44M | $884.00K |
| Total Stockholders Equity | $510.61M | $307.83M | $-314.49M | $-207.00M | $256.39M | $-72.97M | $-27.59M | $-19.59M |
| Total Equity | $510.61M | $307.83M | $-314.49M | $-207.00M | $256.39M | $-72.97M | $-27.59M | $-19.59M |
| Total Liabilities and Stockholders Equity | $560.38M | $339.89M | $-283.98M | $353.49M | $288.33M | $58.23M | $96.97M | $27.32M |
| Minority Interest | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Liabilities and Total Equity | $560.38M | $339.89M | $-283.98M | $353.49M | $288.33M | $58.23M | $96.97M | $27.32M |
| Total Investments | $275.54M | $50.08M | $166.11M | $162.43M | $- | $- | $- | $- |
| Total Debt | $24.61M | $14.67M | $16.12M | $16.45M | $- | $- | $- | $- |
| Net Debt | $-124.73M | $-234.44M | $-202.52M | $-298.98M | $-276.73M | $-49.65M | $-91.76M | $-23.85M |
Cash Flow Statement
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 | December 31, 2018 | December 31, 2017 |
|---|---|---|---|---|---|---|---|---|
| Net Income | $-160.87M | $-100.84M | $-107.49M | $-71.32M | $-56.69M | $-49.31M | $-9.55M | $-11.22M |
| Depreciation and Amortization | $6.71M | $5.75M | $3.88M | $3.02M | $1.44M | $1.00M | $697.00K | $626.00K |
| Deferred Income Tax | $- | $- | $- | $- | $20.00K | $2.65M | $- | $- |
| Stock Based Compensation | $26.12M | $19.66M | $17.12M | $13.80M | $4.98M | $3.54M | $1.38M | $256.00K |
| Change in Working Capital | $537.00K | $630.00K | $-1.34M | $-15.53M | $-711.00K | $259.00K | $-8.78M | $18.54M |
| Accounts Receivables | $- | $- | $47.00K | $1.44M | $-508.00K | $146.00K | $-803.00K | $-320.00K |
| Inventory | $- | $- | $- | $-4.54M | $-591.00K | $2.93M | $175.00K | $-53.00K |
| Accounts Payables | $871.00K | $896.00K | $-1.64M | $2.29M | $43.00K | $533.00K | $438.00K | $-114.00K |
| Other Working Capital | $-334.00K | $-266.00K | $255.00K | $-14.72M | $345.00K | $-3.35M | $-8.59M | $19.03M |
| Other Non Cash Items | $-7.08M | $-999.00K | $1.14M | $898.00K | $48.00K | $5.14M | $2.00K | $39.00K |
| Net Cash Provided by Operating Activities | $-134.59M | $-75.79M | $-86.69M | $-69.13M | $-50.91M | $-36.71M | $-16.25M | $8.24M |
| Investments in Property Plant and Equipment | $- | $-2.77M | $-11.54M | $-9.11M | $-1.00M | $-3.20M | $-414.00K | $-573.00K |
| Acquisitions Net | $- | $- | $11.54M | $9.11M | $- | $- | $- | $24.00K |
| Purchases of Investments | $-467.65M | $-54.80M | $-153.31M | $-168.57M | $- | $- | $- | $- |
| Sales Maturities of Investments | $169.00M | $- | $147.80M | $5.00M | $- | $- | $- | $8.22M |
| Other Investing Activities | $-3.79M | $173.29M | $-11.54M | $-9.11M | $-1.00M | $- | $- | $24.00K |
| Net Cash Used for Investing Activities | $-302.44M | $115.72M | $-17.05M | $-172.68M | $-1.00M | $-3.20M | $-414.00K | $7.67M |
| Debt Repayment | $- | $- | $- | $- | $- | $- | $- | $- |
| Common Stock Issued | $331.41M | $148.34M | $2.73M | $114.30M | $205.66M | $- | $105.00K | $16.00K |
| Common Stock Repurchased | $- | $- | $- | $- | $- | $-2.27M | $- | $- |
| Dividends Paid | $- | $- | $- | $- | $- | $- | $- | $- |
| Other Financing Activities | $5.84M | $8.49M | $3.08M | $3.79M | $73.33M | $-10.00K | $169.05M | $- |
| Net Cash Used Provided by Financing Activities | $337.25M | $156.83M | $3.08M | $118.09M | $278.98M | $-2.19M | $84.58M | $16.00K |
| Effect of Forex Changes on Cash | $- | $- | $- | $- | $- | $- | $- | $- |
| Net Change in Cash | $-99.77M | $196.76M | $-100.65M | $-123.72M | $227.07M | $-42.11M | $67.91M | $15.93M |
| Cash at End of Period | $149.34M | $249.11M | $52.35M | $153.00M | $276.73M | $49.65M | $91.76M | $23.85M |
| Cash at Beginning of Period | $249.11M | $52.35M | $153.00M | $276.73M | $49.65M | $91.76M | $23.85M | $7.92M |
| Operating Cash Flow | $-134.59M | $-75.79M | $-86.69M | $-69.13M | $-50.91M | $-36.71M | $-16.25M | $8.24M |
| Capital Expenditure | $- | $-2.77M | $-11.54M | $-9.11M | $-1.00M | $-3.20M | $-414.00K | $-573.00K |
| Free Cash Flow | $-134.59M | $-78.56M | $-98.22M | $-78.24M | $-51.91M | $-39.91M | $-16.67M | $7.66M |